These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19961874)

  • 21. Pentraxin-3 as a marker of disease activity in Takayasu arteritis.
    Dagna L; Salvo F; Tiraboschi M; Bozzolo EP; Franchini S; Doglioni C; Manfredi AA; Baldissera E; Sabbadini MG
    Ann Intern Med; 2011 Oct; 155(7):425-33. PubMed ID: 21969341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long Pentraxin 3 as a Predictive Marker of Mortality in Severe Septic Patients Who Received Successful Early Goal-Directed Therapy.
    Kim SB; Lee KH; Lee JU; Ann HW; Ahn JY; Jeon YD; Kim JH; Ku NS; Han SH; Choi JY; Song YG; Kim JM
    Yonsei Med J; 2017 Mar; 58(2):370-379. PubMed ID: 28120568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction.
    Matsubara J; Sugiyama S; Nozaki T; Sugamura K; Konishi M; Ohba K; Matsuzawa Y; Akiyama E; Yamamoto E; Sakamoto K; Nagayoshi Y; Kaikita K; Sumida H; Kim-Mitsuyama S; Ogawa H
    J Am Coll Cardiol; 2011 Feb; 57(7):861-9. PubMed ID: 21310324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pentraxin 3].
    Inoue K
    Rinsho Byori; 2011 Jul; 59(7):694-701. PubMed ID: 21874796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pentraxin 3 in children suffering from allergic rhinitis.
    Marseglia GL; De Amici M; Leonardi S; Miraglia Del Giudice M; Salpietro A; La Rosa M; Caimmi D; Caimmi S; Licari A; Ciprandi G
    J Biol Regul Homeost Agents; 2012; 26(1 Suppl):S109-12. PubMed ID: 22691257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
    Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
    Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentraxin 3: a novel and independent prognostic marker in ischemic stroke.
    Ryu WS; Kim CK; Kim BJ; Kim C; Lee SH; Yoon BW
    Atherosclerosis; 2012 Feb; 220(2):581-6. PubMed ID: 22178425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computed tomography severity index and C-reactive protein values predicting mortality in emergency and intensive care units for patients with severe acute pancreatitis.
    Mäkelä JT; Eila H; Kiviniemi H; Laurila J; Laitinen S
    Am J Surg; 2007 Jul; 194(1):30-4. PubMed ID: 17560905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pentraxin-3 level at admission is a strong predictor of short-term mortality in a community-based hospital setting.
    Bastrup-Birk S; Munthe-Fog L; Skjoedt MO; Ma YJ; Nielsen H; Køber L; Nielsen OW; Iversen K; Garred P
    J Intern Med; 2015 May; 277(5):562-72. PubMed ID: 25143177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study.
    Uusitalo-Seppälä R; Huttunen R; Aittoniemi J; Koskinen P; Leino A; Vahlberg T; Rintala EM
    PLoS One; 2013; 8(1):e53661. PubMed ID: 23341967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long pentraxin 3 in cardiac surgery: distinct responses in "on-pump" and "off-pump" patients.
    Kunes P; Lonsky V; Mandak J; Kolackova M; Andrys C; Kudlova M; Krejsek J
    Scand Cardiovasc J; 2007 Jun; 41(3):171-9. PubMed ID: 17487767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pentraxin-3 as a Biomarker for Febrile Neutropenia in Patients with Lung Cancer.
    Takeda N; Asai K; Ijiri N; Yamamoto N; Watanabe T; Kamoi H; Kanazawa H; Hirata K
    Osaka City Med J; 2015 Jun; 61(1):43-52. PubMed ID: 26434104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis.
    van Rossum AP; Pas HH; Fazzini F; Huitema MG; Limburg PC; Jonkman MF; Kallenberg CG
    Arthritis Rheum; 2006 Mar; 54(3):986-91. PubMed ID: 16508993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of in vitro oxidative stress, serum ferritin concentration and C-reactive protein in febrile emergency room patients.
    Huang HH; Yan HC; Han CL; Yu FC; Kao WY; Chen WT
    Clin Invest Med; 2005 Apr; 28(2):48-54. PubMed ID: 15909479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
    Cetin I; Cozzi V; Pasqualini F; Nebuloni M; Garlanda C; Vago L; Pardi G; Mantovani A
    Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions.
    Savchenko A; Imamura M; Ohashi R; Jiang S; Kawasaki T; Hasegawa G; Emura I; Iwanari H; Sagara M; Tanaka T; Hamakubo T; Kodama T; Naito M
    J Pathol; 2008 May; 215(1):48-55. PubMed ID: 18220316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia.
    Kao SJ; Yang HW; Tsao SM; Cheng CW; Bien MY; Yu MC; Bai KJ; Yang SF; Chien MH
    Clin Chem Lab Med; 2013 Apr; 51(4):907-13. PubMed ID: 23152412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early prognostic value of the medical emergency team calling criteria in patients admitted to intensive care from the emergency department.
    Etter R; Ludwig R; Lersch F; Takala J; Merz TM
    Crit Care Med; 2008 Mar; 36(3):775-81. PubMed ID: 18209673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significant elevation of plasma pentraxin 3 in patients with pelvic inflammatory disease.
    Chang CC; Wang PH; Su PH; Lin DB; Ying TH; Yang SF; Hsieh YH
    Clin Chem Lab Med; 2011 Oct; 49(10):1655-60. PubMed ID: 21679133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy.
    Akolekar R; Casagrandi D; Livanos P; Tetteh A; Nicolaides KH
    Prenat Diagn; 2009 Oct; 29(10):934-8. PubMed ID: 19565609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.